Inventor · disambiguated record
Robert Adam Uger
Also filed as: UGER ROBERT · UGER ROBERT A · UGER ROBERT ADAM
4 granted patents·13 pending applications·46 citations·filing 2003–2023
74Inventor score
Files withTRILLIUM THERAPEUTICS INC7PF ARGENTUM IP HOLDINGS LLC3PFIZER3AVENTIS PASTEUR1AVENTIS PASTEUR INC1
Top patents by PatentIndex Score
17 records- 0190US10906954B2Treatment of CD47+ disease cells with SIRPα-Fc fusionsTRILLIUM THERAPEUTICS INC·Filed 2018·Granted Feb 2, 2021·11 cites·14 claims
- 0290US9969789B2Treatment of CD47+ disease cells with SIRP alpha-Fc fusionsTRILLIUM THERAPEUTICS INC·Filed 2013·Granted May 15, 2018·33 cites·4 claims
- 0365US2024018258A1Cd47 blockade therapy with cd38 antibodyPFIZER·Filed 2023·Application pending·0 cites
- 0464US11446315B2Enhancement of CD47 blockade therapy by proteasome inhibitorsPF ARGENTUM IP HOLDINGS LLC·Filed 2017·Granted Sep 20, 2022·2 cites·29 claims
- 0560US2021206829A1Treatment of cd47+ disease cells with sirp alpha-fc fusionsTRILLIUM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0657US2025367255A1Enhancement Of CD47 Blockade Therapy With Anti-VEGF AgentsPFIZER·Filed 2022·Application pending·0 cites
- 0755US2023087443A1Enhancement of cd47 blockade therapy by proteasome inhibitorsPF ARGENTUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 0853US2025235504A1Enhancement of cd47 blockade with taxanes for cd47+ cancer therapyPFIZER·Filed 2022·Application pending·0 cites
- 0953US2021040224A1Cd47 blockade therapy with cd38 antibodyTRILLIUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1049US2024423983A1Enhancement of cd47 blockade therapy with dhfr inhibitorsPF ARGENTUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1147US11779631B2CD47 blockade therapy by HDAC inhibitorsTrillium Therapeutics ULC·Filed 2017·Granted Oct 10, 2023·0 cites·17 claims
- 1247US2004002455A1Targeted immunogensAVENTIS PASTEUR·Filed 2003·Application pending·0 cites
- 1346US2006002946A1Targeted immunogensAVENTIS PASTEUR INC·Filed 2004·Application pending·0 cites
- 1444US2021040219A1Improvements in cd47 blockade therapy by egfr antibodyTRILLIUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1539US2020157179A1Cd47 blockade therapyTRILLIUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1639US2013102532A1HB-EGF Composition and Use Thereof to Treat a Condition Associated With Enhanced Urothelium PermeabilityUGER ROBERT·Filed 2011·Application pending·0 cites
- 1737US2019091290A1Macrophage stimulation in cd47 blockade therapyTRILLIUM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Adam Uger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →